Herbal and Traditional Product Registration in Bhutan – regulatory works



Herbal and Traditional Product Registration in Bhutan – regulatory works

Published on 18/12/2025

Herbal and Traditional Product Registration in Bhutan

The registration of herbal and traditional products in Bhutan is a critical aspect of the country’s healthcare landscape. With increasing global interest in traditional medicine and herbal supplements, it is essential for companies to understand the regulatory framework set forth by Bhutan’s Drug Regulatory Authority (DRA). This article provides a comprehensive step-by-step guide outlining the regulatory works required for the registration of herbal and traditional products in Bhutan.

Step 1: Understand Regulatory Framework and Key Definitions

Before initiating the registration process, it is crucial to become familiar with Bhutan’s regulatory landscape concerning herbal and traditional products. The DRA is the primary regulatory body responsible for overseeing the safety, efficacy, and quality of medicines, including herbal products. The key regulations that govern herbal and traditional product registration include:

  • Bhutanese Medicines Act
  • Good Manufacturing Practices (GMP) guidelines
  • Guidelines on Marketing Authorization for Traditional Medicines

Additionally, it is important to differentiate between various product categories under the Bhutanese jurisdiction:

  • Herbal Products: Defined as products exclusively derived from plants.
  • Traditional Medicine: Encompasses
treatments and remedies based on ancient practices.
  • Cosmetic Products: These products are subject to different regulations and primarily focus on external application.
  • Each of these categories has distinct regulatory pathways and requirements that you must understand thoroughly. The DRA has also issued guidelines pertaining to the quality and labeling of herbal products, which must be adhered to during the registration process.

    Step 2: Prepare Your Dossier for Submission

    The dossier is a critical element in the registration process. It serves as a comprehensive document that presents all relevant information about the product, justifying its safety, efficacy, and quality. The key sections of the dossier generally include:

    • Product Information: Name, composition, and intended use.
    • Manufacturing Information: Description of the manufacturing process and facilities, demonstrating compliance with GMP standards.
    • Quality Control: Analytical methods for testing raw materials and finished products.
    • Clinical Evidence: Any clinical data supporting the efficacy and safety claims must be presented. This may involve literature references or results from clinical trials.
    • Labeling and Packaging: Detailed labeling draft that meets regulatory expectations, including ingredient lists, usage instructions, and storage conditions.

    It is essential to ensure that each section of the dossier is well-researched, concise, and thoroughly referenced. You may also want to consult with experts in global regulatory affairs to ensure that your dossier aligns with international standards, particularly if you plan to market the product outside Bhutan.

    Step 3: Submit Your Application

    Once the dossier has been prepared, it is time to submit the application to the DRA. The following steps encompass the submission process:

    1. Application Form Completion: Fill out the necessary application forms specific to herbal products as required by the DRA.
    2. Fees Payment: Pay the required regulatory fees aligned with the marketing authorization for herbal product registration.
    3. Documentation Review: Ensure that all documents are compiled and reviewed for completeness. This includes the dossier and any accompanying forms.
    4. Submission of Documents: Submit the complete application package to the DRA via the specified submission method, whether in person or electronically.

    Upon submission, obtain a receipt or acknowledgment from the DRA, which will serve as proof and can provide a timeline estimate for the review process. Understand that incomplete submissions can lead to delays or requests for additional information, so meticulous attention to detail is crucial.

    Step 4: Regulatory Review Process

    The DRA will conduct a comprehensive review of submitted applications, which typically encompasses several phases. During this period, it is vital to be ready for potential inquiries from the regulatory authority. Here’s what to expect during the review process:

    • Screening of Application: Initial checks will determine if the application meets basic requirements before proceeding to a full evaluation.
    • Technical Review: Experts will evaluate the quality, safety, and efficacy data presented in your dossier. This phase involves scrutinizing manufacturing processes, clinical evidence, and compliance with local guidelines.
    • Quality Assurance Assessments: A quality assurance team may carry out an inspection of manufacturing sites to confirm adherence to GMP standards.
    • Timeline for Decision: Standard timelines vary, but applicants should expect a decision often within a few months, depending on the complexity of the product and the completeness of the submission.

    During this period, clear communication with the DRA may be essential. Responding promptly to any information requests or inquiries is crucial to ensure a smooth and timely review process.

    Step 5: Approval and Post-Marketing Surveillance

    Upon successful completion of the review, the DRA will grant marketing authorization for your herbal or traditional product. However, receiving approval is only the beginning of the regulatory lifecycle. Following approval, several responsibilities must be adhered to:

    • Labeling Compliance: Ensure that all product labeling reflects the approved information, including claims made during the application process.
    • Pharmacovigilance Duties: Implement a pharmacovigilance system to monitor the safety of the product during its lifecycle. Regularly report adverse events to the DRA.
    • Periodic Safety Update Reports (PSURs): Some products may require submission of PSURs to provide ongoing assessments of the product’s safety profile.
    • Quality System Maintenance: Conduct internal audits and inspections regularly to maintain quality and regulatory compliance in production and distribution.

    Furthermore, companies must continuously engage with updates in regulatory guidelines as they evolve. This vigilance is essential to maintain compliance not only locally but also in anticipation of potential export requirements.

    Conclusion

    Registering herbal and traditional products in Bhutan requires a thorough understanding of the regulatory requirements set forth by the Drug Regulatory Authority. By following the outlined steps, stakeholders in the pharmaceutical and herbal sectors can navigate the registration process with greater confidence and clarity. Emphasis must be placed on accurate documentation, adherence to GMP standards, and maintaining compliance post-approval.

    As global interest in natural and traditional remedies continues to rise, ensuring compliance with regulatory frameworks such as these will facilitate the process of bringing such products to market while safeguarding public health and promoting broader access to effective treatments.